R-Tech Ueno: Basic Agreement on the Supply of Recombinant Human Serum Albumin

October 18, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573) and Novozymes Biopharma DK A/S (hereinafter referred to as Novozymes) reached a basic agreement today on the supply of recombinant human serum albumin as described below:

Twitter
LinkedIn
Facebook
Email
Print

Alliances Asia Europe